Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1

Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1

2.6% of pancreatic cancer patients have the primary manifestation of gastrointestinal bleeding. It is not feasible to stop the duodenal hemorrhage caused by the pancreatic cancer infiltration. A 43-year-old woman who was diagnosed as having pancreatic cancer with multiple hepatic metastases and duod...

Full description

Bibliographic Details
Main Authors: Ryoji Takada, Tatsuya Ioka, Hironari Sueyoshi, Nobuko Ishida, Takuo Yamai, Nobuyasu Fukutake, Reiko Ashida, Hiroyuki Uehara, Akemi Takenaka, Yasuhiko Tomita, Kazuhiro Katayama
Format: Article
Language:English
Published: Karger Publishers 2014-06-01
Series:Case Reports in Gastroenterology
Subjects:
Chemotherapy
Gastrointestinal bleeding
Pancreatic cancer
Duodenal infiltration
Online Access:http://www.karger.com/Article/FullText/364819

Internet

http://www.karger.com/Article/FullText/364819

Similar Items